Booth Bruce's Form 4 filing
Kymera Therapeutics, Inc.KYMR · filed Jun 25, 2026
- Accession no.
- 0001451612-26-000016
- Filed
- Jun 25, 2026
- Trade date
- Jun 25, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 22 non-derivative transactions. Open-market sales total $34.8M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Booth BruceCIK 0001451612 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | SSaleDisposed | −37,179 | $119.71F2 | −$4,450,698.09 | 3,075,906 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −112,299 | $120.66F4 | −$13,549,997.34 | 2,963,607 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −40,774 | $121.38F5 | −$4,949,148.12 | 2,922,833 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −4,977 | $122.67F6 | −$610,528.59 | 2,917,856 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −10,860 | $123.62F7 | −$1,342,513.2 | 2,906,996 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −11,711 | $124.61F8 | −$1,459,307.71 | 2,895,285 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −3,716 | $125.82F9 | −$467,547.12 | 2,891,569 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,609 | $126.71F10 | −$203,876.39 | 2,889,960 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −25,075 | $127.37F11 | −$3,193,802.75 | 2,864,885 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −2,197 | $128.69F12 | −$282,731.93 | 2,862,688 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −337 | $129.61F13 | −$43,678.57 | 2,862,351 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −5,144 | $119.71F2 | −$615,788.24 | 559,524 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −15,660 | $120.66F4 | −$1,889,535.6 | 543,864 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −5,689 | $121.38F5 | −$690,530.82 | 538,175 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −698 | $122.67F6 | −$85,623.66 | 537,477 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,517 | $123.62F7 | −$187,531.54 | 535,960 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,639 | $124.61F8 | −$204,235.79 | 534,321 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −522 | $125.82F9 | −$65,678.04 | 533,799 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −223 | $126.71F10 | −$28,256.33 | 533,576 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −3,507 | $127.37F11 | −$446,686.59 | 530,069 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −305 | $128.69F12 | −$39,250.45 | 529,764 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −46 | $129.61F13 | −$5,962.06 | 529,718 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.08 to $120.0798 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (4) through (13).
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.08 to $121.0794 inclusive.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.08 to $122.0731 inclusive.
Referenced by the price of 2 transactions in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.0858 to $123.08 inclusive.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.09 to $124.08 inclusive.
Referenced by the price of 2 transactions in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.09 to $125.0292 inclusive.
Referenced by the price of 2 transactions in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.1194 to $126.115 inclusive.
Referenced by the price of 2 transactions in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.13 to $127.0511 inclusive.
Referenced by the price of 2 transactions in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.30 to $128.2975 inclusive.
Referenced by the price of 2 transactions in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.3008 to $129.2819 inclusive.
Referenced by the price of 2 transactions in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.3041 to $130.05 inclusive.
Referenced by the price of 2 transactions in Table I.
Remarks
Due to the 30 line limitation in Table I, this report is being filed across two forms. This is the second of two filings.